We report a case of oral acetaminophen toxicity in a term newborn infant successfully treated with a 20 h intravenous N-acetylcysteine infusion protocol without any adverse effects. This case report supports the use of N-acetylcysteine to treat neonatal acetaminophen toxicity and highlights the need for better education of parents regarding the appropriate use and dosage of acetaminophen in newborns. Journal of Perinatology (2007Perinatology ( ) 27, 133-135. doi:10.1038 Keywords: Neonatal acetaminophen toxicity; hepatic failure; N-acetylcysteine
Introduction
Acetaminophen is an efficacious and safe analgesic used often in newborns. 1 Although it is relatively safe, acetaminophen toxicity is well documented and can lead to liver failure and even death. The risk of developing toxicity is, in general, thought to be lower in children than in adults. N-acetylcysteine (NAC) is the treatment of choice for acetaminophen overdose in older children and adults. To date, there are no documented neonatal cases of oral acetaminophen toxicity with hepatic encephalopathy. We report a case of oral acetaminophen toxicity presenting with hepatic encephalopathy and oliguric renal failure in a term newborn infant successfully treated with intravenous NAC without observable adverse effects.
Case report A four day-old term male infant was brought to the emergency department after episodic emesis and decreased level of arousal. He was born to a 24 year-old mother following an uncomplicated pregnancy by normal spontaneous vaginal delivery at 41 weeks gestational age. Apgar scores were 9 at 1 min and 9 at 5 min. He was discharged on the second postnatal day after circumcision.
One day later he became sleepy, fed poorly and vomited approximately 10 times in 24 h. The baby was evaluated by a visiting nurse, who sent him to the emergency department. On examination he was moderately dehydrated, lethargic and poorly responsive to stimulation. Gastric lavage produced blood-tinged aspirates. Significant laboratory findings included glucose 27 mg/dl (normal: 45 to 120 mg/dl), Na 149 mEq/l (normal: 135 to 148 mEq/l), K 5.9 mEq/l, Cl 110 mEq/l (normal: 91 to 111 mEq/l), CO 2 18 mEq/l, BUN 40 mg/dl, creatinine 3. Cerebral spinal fluid analysis was normal. The baby received intravenous volume expansion, dextrose and ampicillin and cefotaxime. He was admitted to the neonatal intensive care unit with a presumptive diagnosis of sepsis with renal failure, liver failure and coagulopathy. An arterial blood gas analysis after fluid boluses revealed pH 7.42, pCO 2 28 torr and bicarbonate 18 mEq/l. The baby remained persistently encephalopathic despite the correction of hypoglycemia, dehydration and electrolyte imbalance. Further questioning of the parents revealed that the infant had been receiving acetaminophen every 4 h since his circumcision on the second day of life. Review of dosing determined that he had received 80 mg (26 mg/kg) every 4 h for the first 24 h, then 40 mg (13 mg/kg) every 4 h for the next 2 days. Acetaminophen concentration was then measured 16 h after his last dose at home and found to be 109.8 mg/ml (therapeutic range 10 to 30 mg/ml).
The clinical manifestations of the baby were consistent with acetaminophen toxicity. Treatment with a 20 h intravenous NAC infusion protocol 3 was initiated with a 150 mg/kg bolus of NAC given over 15 min, followed by a 50 mg/kg dose over 4 h and then 100 mg/kg over 16 h. A concentration of 40 mg/ml in 5% dextrose was used to avoid volume overload and hyponatremia. 3 Subsequent doses of NAC were given in 100 mg/kg aliquots over 16 h until the acetaminophen concentration was undetectable. Other supportive measures included transfusions of fresh frozen plasma and cryoprecipitate to correct coagulopathy; fluid boluses and furosemide to induce diuresis; high dextrose and restricted protein; ranitidine for blood-tinged gastric aspirates; and enteral lactulose therapy to cause increased stooling.
On the first hospital day, his encephalopathy worsened with the development of recurrent seizures, for which he was treated with phenobarbital. A computed tomographic brain scan demonstrated slit-like ventricles but preserved grey-white matter differentiation. With NAC therapy, his acetaminophen concentrations gradually decreased to <10 mg/ml at 56 h after the last oral dose of acetaminophen given at home (Table 1) . His clinical picture improved over several days, and he became more alert. His coagulation profile normalized, and liver and renal function studies improved to PT 12.4 s, PTT 44.7 s, INR 1.2, factor V assay 93%, fibrinogen 290 mg/l, AST 107 IU/l, ALT 326 IU/l, serum bilirubin 2.4 mg/dl with a conjugated fraction of 0.6 mg/dl, and serum creatinine 0.4 mg/dl, respectively, on the third hospital day. A restricted protein and lactose free diet was started on the third hospital day and the patient was discharged on a regular diet on the seventh hospital day. The rest of his evaluation, including blood, CSF and urine cultures, cerebral spinal fluid PCR for herpes simplex virus, state newborn screen, galactose-1-phosphate RBC, serum amino acids, urine organic acids and acyl-carnitine profile, was unremarkable. He was developing normally without apparent long-term effects during his follow-up visit at 9 months of age.
Discussion
Over the past decade, there has been an increased effort to ensure that infants receive adequate pain control after circumcision. Studies show that infants who received acetaminophen before circumcision have significantly lower pain scores 6 h after the procedure. 4 Routine use of acetaminophen before circumcision, with repeated doses every 4 to 6 h for the initial 24 h following the procedure, 5 is usually recommended, but repeated oral acetaminophen doses in a newborn may lead to detrimental effects as illustrated in this case. This baby was receiving an infant formulation of acetaminophen every 4 h, for presumed pain after circumcision. The parents, however, did not give him the medication based on signs of pain, but in the belief that acetaminophen was safe and would not cause any harm if given every four hours as instructed by hospital personnel. Questions arising from this case include the safety of acetaminophen in the neonatal period and the necessity to adequately counsel parents. Adverse effects of acetaminophen are related to the unique pharmacokinetics and metabolism in the newborn when compared with an older child or adult. The average elimination half-life in infants is prolonged and is reported to be 3.5 vs 1.9-2.2 h in adults. 6 Because of the prolonged half-life leading to accumulation of the drug, repeated doses of acetaminophen in short intervals are of particular concern. 6 Hepatotoxicity from an acetaminophen overdose is mediated by the reactive metabolic intermediate N-acetyl-p-benzoquinoneimine (NAPQI), which is normally detoxified by reduced glutathione. 3 The reserves of glutathione needed for detoxification of NAPQI may be depleted after supratherapeutic or repeated therapeutic doses of acetaminophen. 6 NAC is thought to have a therapeutic effect in acetaminophen toxicity by regeneration of reduced glutathione. 3 Complete recovery following treatment with NAC in this case also highlights the fact that newborns and young children are more resilient to hepatic necrosis and failure than older children and adults. This may be related to reduced rates of metabolism by the CYP450 system in the neonatal liver and the newborn's increased ability to synthesize glutathione. 7 Currently, there are two published intravenous NAC treatment protocols that are used in acetaminophen overdose in children and adults. 3 Anaphylactoid reactions (which can occur in up to 10% of patients) tend to be more significant with intravenous NAC compared to oral NAC. There are few toxicokinetic data of neonatal acetaminophen overdose available, 8 and the protocol used to treat acetaminophen toxicity in this case was based on adult studies. The adult 20 h intravenous NAC protocol 2 can be used to treat severe hepatic and oliguric renal failure in newborns effectively without significant adverse effects, as demonstrated in this case.
There is clearly a need for more education of parents regarding the appropriate use and dosage of acetaminophen. Health care providers should be cautious when suggesting repeated doses of acetaminophen for pain control after circumcision in newborns. To prevent potential acetaminophen overdose, it is especially important to educate parents not to use acetaminophen at all beyond 24 h post-circumcision unless there is evidence of pain. 
